The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Rallybio Corporation(NASDAQ:RLYB)


Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead program is RLYB212, a preclinical-stage monoclonal anti-HPA-1a antibody for t...
Share this website to your friends
Rallybio Days Payable Outstanding ttm (DPO)
Rallybio Op Cashflow Per Share ttm
Rallybio Free Cashflow Per Share ttm
Rallybio Cash Per Share ttm
Rallybio (GAAP) P/E ratio ttm
Rallybio P/B ratio ttm
No extra charts and metrics for this ticker.